HEADER SIGNALING PROTEIN/ANTIBIOTIC 05-MAY-11 3RUL TITLE NEW STRATEGY TO ANALYZE STRUCTURES OF GLYCOPEPTIDE-TARGET COMPLEXES COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: DALBAVANCIN; COMPND 7 CHAIN: E, F, G, H; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UBC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS ANTIBIOTIC, GLYCOPEPTIDE, NATIVE PROTEIN LIGATION, FUSION, KEYWDS 2 CARBOXYMETHYLATION OF CYSTEINE, DALBAVANCIN, SIGNALING PROTEIN- KEYWDS 3 ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.J.ECONOMOU,V.NAHOUM,S.D.WEEKS,K.C.GRASTY,P.J.LOLL REVDAT 4 06-DEC-23 3RUL 1 LINK REVDAT 3 13-SEP-23 3RUL 1 HETSYN REVDAT 2 29-JUL-20 3RUL 1 COMPND REMARK SEQRES HETNAM REVDAT 2 2 1 LINK SITE ATOM REVDAT 1 06-JUN-12 3RUL 0 JRNL AUTH N.J.ECONOMOU,V.NAHOUM,S.D.WEEKS,K.C.GRASTY,I.J.ZENTNER, JRNL AUTH 2 T.M.TOWNSEND,M.W.BHUIYA,S.COCKLIN,P.J.LOLL JRNL TITL A CARRIER PROTEIN STRATEGY YIELDS THE STRUCTURE OF JRNL TITL 2 DALBAVANCIN. JRNL REF J.AM.CHEM.SOC. V. 134 4637 2012 JRNL REFN ISSN 0002-7863 JRNL PMID 22352468 JRNL DOI 10.1021/JA208755J REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.6.2_432 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 17635 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 907 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.6032 - 4.5272 1.00 2956 134 0.2022 0.2181 REMARK 3 2 4.5272 - 3.6007 1.00 2817 134 0.2200 0.2742 REMARK 3 3 3.6007 - 3.1476 1.00 2762 150 0.2791 0.2683 REMARK 3 4 3.1476 - 2.8608 1.00 2747 172 0.2926 0.3597 REMARK 3 5 2.8608 - 2.6563 1.00 2736 159 0.3195 0.3448 REMARK 3 6 2.6563 - 2.5000 1.00 2710 158 0.3207 0.3771 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 32.82 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.900 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.76 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -21.89540 REMARK 3 B22 (A**2) : 40.76180 REMARK 3 B33 (A**2) : -18.86630 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3112 REMARK 3 ANGLE : 1.285 4236 REMARK 3 CHIRALITY : 0.083 484 REMARK 3 PLANARITY : 0.008 536 REMARK 3 DIHEDRAL : 13.910 1268 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 7 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 1:16 REMARK 3 SELECTION : CHAIN B AND RESSEQ 1:16 REMARK 3 ATOM PAIRS NUMBER : 126 REMARK 3 RMSD : 0.036 REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 1:16 REMARK 3 SELECTION : CHAIN C AND RESSEQ 1:16 REMARK 3 ATOM PAIRS NUMBER : 126 REMARK 3 RMSD : 0.034 REMARK 3 NCS OPERATOR : 3 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 1:16 REMARK 3 SELECTION : CHAIN D AND RESSEQ 3:15 REMARK 3 ATOM PAIRS NUMBER : 100 REMARK 3 RMSD : 0.038 REMARK 3 NCS GROUP : 2 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 17:24 REMARK 3 SELECTION : CHAIN B AND RESSEQ 17:24 REMARK 3 ATOM PAIRS NUMBER : 61 REMARK 3 RMSD : 0.023 REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 17:24 REMARK 3 SELECTION : CHAIN C AND RESSEQ 17:24 REMARK 3 ATOM PAIRS NUMBER : 61 REMARK 3 RMSD : 0.028 REMARK 3 NCS OPERATOR : 3 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 17:24 REMARK 3 SELECTION : CHAIN D AND RESSEQ 17:24 REMARK 3 ATOM PAIRS NUMBER : 61 REMARK 3 RMSD : 0.021 REMARK 3 NCS GROUP : 3 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 26:32 REMARK 3 SELECTION : CHAIN B AND RESSEQ 26:32 REMARK 3 ATOM PAIRS NUMBER : 55 REMARK 3 RMSD : 0.037 REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 26:32 REMARK 3 SELECTION : CHAIN C AND RESSEQ 26:32 REMARK 3 ATOM PAIRS NUMBER : 55 REMARK 3 RMSD : 0.035 REMARK 3 NCS OPERATOR : 3 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 26:32 REMARK 3 SELECTION : CHAIN D AND RESSEQ 26:32 REMARK 3 ATOM PAIRS NUMBER : 55 REMARK 3 RMSD : 0.027 REMARK 3 NCS GROUP : 4 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 34:39 REMARK 3 SELECTION : CHAIN B AND RESSEQ 34:39 REMARK 3 ATOM PAIRS NUMBER : 43 REMARK 3 RMSD : 0.037 REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 34:39 REMARK 3 SELECTION : CHAIN C AND RESSEQ 34:39 REMARK 3 ATOM PAIRS NUMBER : 43 REMARK 3 RMSD : 0.033 REMARK 3 NCS OPERATOR : 3 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 34:39 REMARK 3 SELECTION : CHAIN D AND RESSEQ 34:39 REMARK 3 ATOM PAIRS NUMBER : 43 REMARK 3 RMSD : 0.032 REMARK 3 NCS GROUP : 5 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 41:71 REMARK 3 SELECTION : CHAIN B AND RESSEQ 41:71 REMARK 3 ATOM PAIRS NUMBER : 252 REMARK 3 RMSD : 0.032 REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 41:71 REMARK 3 SELECTION : CHAIN C AND RESSEQ 41:71 REMARK 3 ATOM PAIRS NUMBER : 252 REMARK 3 RMSD : 0.034 REMARK 3 NCS OPERATOR : 3 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 41:71 REMARK 3 SELECTION : CHAIN D AND RESSEQ 41:71 REMARK 3 ATOM PAIRS NUMBER : 252 REMARK 3 RMSD : 0.027 REMARK 3 NCS GROUP : 6 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 74:77 REMARK 3 SELECTION : CHAIN B AND RESSEQ 74:77 REMARK 3 ATOM PAIRS NUMBER : 30 REMARK 3 RMSD : 0.033 REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 74:77 REMARK 3 SELECTION : CHAIN C AND RESSEQ 74:77 REMARK 3 ATOM PAIRS NUMBER : 30 REMARK 3 RMSD : 0.030 REMARK 3 NCS OPERATOR : 3 REMARK 3 REFERENCE SELECTION: CHAIN A AND RESSEQ 74:77 REMARK 3 SELECTION : CHAIN D AND RESSEQ 74:77 REMARK 3 ATOM PAIRS NUMBER : 30 REMARK 3 RMSD : 0.036 REMARK 3 NCS GROUP : 7 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN F AND RESSEQ 1:7 REMARK 3 SELECTION : CHAIN G AND RESSEQ 1:7 REMARK 3 ATOM PAIRS NUMBER : 84 REMARK 3 RMSD : 0.088 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3RUL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065395. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16489 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 19.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 16.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3ANJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG3350, 0.2M AMMONIUM TARTRATE, REMARK 280 0.015M CYMAL-7, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.65000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.59500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.12500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.59500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.65000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.12500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 DALBAVANCIN IS A TETRACYCLIC LIPOGLYCOPEPTIDE. THE SCAFFOLD IS REMARK 400 A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L. IT IS REMARK 400 FURTHER GLYCOSYLATED BY MONSACCHARIDES 2-AMINO-2-DEOXY-BETA- REMARK 400 D-GLUCOPYRANURONIC ACIDRISTOSAMINE AND D-MANNOSE AND HAS REMARK 400 FATTY ACID METHYLUNDECANOIC ACID. REMARK 400 HERE, DALBAVANCIN IS REPRESENTED BY GROUPING TOGETHER THE REMARK 400 SEQUENCE (SEQRES) AND THE THREE LIGANDS (HET) MAN, N1L, AND M12. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DALBAVANCIN REMARK 400 CHAIN: E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7 REMARK 400 COMPONENT_2: SUGAR (2-AMINO-2-DEOXY-BETA-D-GLUCOPYRANURONIC ACID) REMARK 400 COMPONENT_3: SUGAR (ALPHA-D-MANNOSE) REMARK 400 COMPONENT_4: METHYLUNDECANOIC ACID REMARK 400 DESCRIPTION: DALBAVANCIN IS A TETRACYCLIC LIPOGLYCOPEPTIDE, REMARK 400 GLYCOSYLATED BY A MONOSACCHARIDE REMARK 400 ON RESIDUE 4 (RESIDUE 8), AND A MONOSACCHARIDE REMARK 400 ON RESIDUE 7 (RESIDUE 9) AND HAS FATTY ACID REMARK 400 METHYLUNDECANOIC ACID (RESIDUE 10). REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 CCS A 76 CD CE OZ1 OZ2 REMARK 470 CCS B 76 CD CE OZ1 OZ2 REMARK 470 CCS C 76 CD CE OZ1 OZ2 REMARK 470 CCS D 76 CD CE OZ1 OZ2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N2 N1L H 8 O1 M12 H 10 2.07 REMARK 500 N2 N1L F 8 O1 M12 F 10 2.11 REMARK 500 N2 N1L G 8 O1 M12 G 10 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HCL F 3 -35.54 -131.02 REMARK 500 HCL G 3 -33.89 -130.84 REMARK 500 OMY G 6 116.81 -5.93 REMARK 500 HCL H 3 -31.83 -134.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GHP G 5 OMY G 6 -94.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3A9J RELATED DB: PDB REMARK 900 HIGH RESOLUTION CRYSTAL STRUCTURE OF THE MOUSE TAB2-NZF IN COMPLEX REMARK 900 WITH LYS63-LINKED DI-UBIQUITIN REMARK 900 RELATED ID: 3RUM RELATED DB: PDB REMARK 900 RELATED ID: 3RUN RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS STATE THAT THESE RESIDUES ARE LIGATED NON-RECOMBINANTLY REMARK 999 WITH NATIVE PROTEIN LIGATION AFTER PROTEIN EXPRESSION AND REMARK 999 PURIFICATION. DBREF 3RUL A 1 75 UNP P0CG48 UBC_HUMAN 1 75 DBREF 3RUL B 1 75 UNP P0CG48 UBC_HUMAN 1 75 DBREF 3RUL C 1 75 UNP P0CG48 UBC_HUMAN 1 75 DBREF 3RUL D 1 75 UNP P0CG48 UBC_HUMAN 1 75 DBREF 3RUL E 1 7 PDB 3RUL 3RUL 1 7 DBREF 3RUL F 1 7 PDB 3RUL 3RUL 1 7 DBREF 3RUL G 1 7 PDB 3RUL 3RUL 1 7 DBREF 3RUL H 1 7 PDB 3RUL 3RUL 1 7 SEQADV 3RUL CCS A 76 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL LYS A 77 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL DAL A 78 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL DAL A 79 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL CCS B 76 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL LYS B 77 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL DAL B 78 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL DAL B 79 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL CCS C 76 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL LYS C 77 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL DAL C 78 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL DAL C 79 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL CCS D 76 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL LYS D 77 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL DAL D 78 UNP P0CG48 SEE REMARK 999 SEQADV 3RUL DAL D 79 UNP P0CG48 SEE REMARK 999 SEQRES 1 A 79 MET GLN ILE PHE VAL LYS THR LEU THR GLY LYS THR ILE SEQRES 2 A 79 THR LEU GLU VAL GLU PRO SER ASP THR ILE GLU ASN VAL SEQRES 3 A 79 LYS ALA LYS ILE GLN ASP LYS GLU GLY ILE PRO PRO ASP SEQRES 4 A 79 GLN GLN ARG LEU ILE PHE ALA GLY LYS GLN LEU GLU ASP SEQRES 5 A 79 GLY ARG THR LEU SER ASP TYR ASN ILE GLN LYS GLU SER SEQRES 6 A 79 THR LEU HIS LEU VAL LEU ARG LEU ARG GLY CCS LYS DAL SEQRES 7 A 79 DAL SEQRES 1 B 79 MET GLN ILE PHE VAL LYS THR LEU THR GLY LYS THR ILE SEQRES 2 B 79 THR LEU GLU VAL GLU PRO SER ASP THR ILE GLU ASN VAL SEQRES 3 B 79 LYS ALA LYS ILE GLN ASP LYS GLU GLY ILE PRO PRO ASP SEQRES 4 B 79 GLN GLN ARG LEU ILE PHE ALA GLY LYS GLN LEU GLU ASP SEQRES 5 B 79 GLY ARG THR LEU SER ASP TYR ASN ILE GLN LYS GLU SER SEQRES 6 B 79 THR LEU HIS LEU VAL LEU ARG LEU ARG GLY CCS LYS DAL SEQRES 7 B 79 DAL SEQRES 1 C 79 MET GLN ILE PHE VAL LYS THR LEU THR GLY LYS THR ILE SEQRES 2 C 79 THR LEU GLU VAL GLU PRO SER ASP THR ILE GLU ASN VAL SEQRES 3 C 79 LYS ALA LYS ILE GLN ASP LYS GLU GLY ILE PRO PRO ASP SEQRES 4 C 79 GLN GLN ARG LEU ILE PHE ALA GLY LYS GLN LEU GLU ASP SEQRES 5 C 79 GLY ARG THR LEU SER ASP TYR ASN ILE GLN LYS GLU SER SEQRES 6 C 79 THR LEU HIS LEU VAL LEU ARG LEU ARG GLY CCS LYS DAL SEQRES 7 C 79 DAL SEQRES 1 D 79 MET GLN ILE PHE VAL LYS THR LEU THR GLY LYS THR ILE SEQRES 2 D 79 THR LEU GLU VAL GLU PRO SER ASP THR ILE GLU ASN VAL SEQRES 3 D 79 LYS ALA LYS ILE GLN ASP LYS GLU GLY ILE PRO PRO ASP SEQRES 4 D 79 GLN GLN ARG LEU ILE PHE ALA GLY LYS GLN LEU GLU ASP SEQRES 5 D 79 GLY ARG THR LEU SER ASP TYR ASN ILE GLN LYS GLU SER SEQRES 6 D 79 THR LEU HIS LEU VAL LEU ARG LEU ARG GLY CCS LYS DAL SEQRES 7 D 79 DAL SEQRES 1 E 7 HGM DTY HCL GHP GHP OMY HG7 SEQRES 1 F 7 HGM DTY HCL GHP GHP OMY HG7 SEQRES 1 G 7 HGM DTY HCL GHP GHP OMY HG7 SEQRES 1 H 7 HGM DTY HCL GHP GHP OMY HG7 HET CCS A 76 6 HET DAL A 78 5 HET DAL A 79 6 HET CCS B 76 6 HET DAL B 78 5 HET DAL B 79 6 HET CCS C 76 6 HET DAL C 78 5 HET DAL C 79 6 HET CCS D 76 6 HET DAL D 78 5 HET DAL D 79 6 HET HGM E 1 12 HET DTY E 2 12 HET HCL E 3 13 HET GHP E 4 11 HET GHP E 5 11 HET OMY E 6 14 HET HG7 E 7 18 HET HGM F 1 12 HET DTY F 2 12 HET HCL F 3 13 HET GHP F 4 11 HET GHP F 5 11 HET OMY F 6 14 HET HG7 F 7 18 HET HGM G 1 12 HET DTY G 2 12 HET HCL G 3 13 HET GHP G 4 11 HET GHP G 5 11 HET OMY G 6 14 HET HG7 G 7 18 HET HGM H 1 12 HET DTY H 2 12 HET HCL H 3 13 HET GHP H 4 11 HET GHP H 5 11 HET OMY H 6 14 HET HG7 H 7 18 HET TLA A 101 10 HET TLA A 102 10 HET TLA B 101 10 HET TLA B 102 10 HET CL B 103 1 HET N1L E 8 12 HET MAN E 9 12 HET M12 E 10 13 HET N1L F 8 12 HET MAN F 9 12 HET M12 F 10 13 HET N1L G 8 12 HET MAN G 9 12 HET M12 G 10 13 HET N1L H 8 12 HET MAN H 9 12 HET M12 H 10 13 HETNAM CCS CARBOXYMETHYLATED CYSTEINE HETNAM DAL D-ALANINE HETNAM HGM (2R)-2-(4-HYDROXYPHENYL)-2-(METHYLAMINO)ETHANOIC ACID HETNAM DTY D-TYROSINE HETNAM HCL (2S)-2-AZANYL-2-[2-CHLORANYL-3,5-BIS(OXIDANYL) HETNAM 2 HCL PHENYL]ETHANOIC ACID HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM OMY (BETAR)-3-CHLORO-BETA-HYDROXY-L-TYROSINE HETNAM HG7 (2S)-2-AZANYL-N-[3-(DIMETHYLAMINO)PROPYL]-2-(3- HETNAM 2 HG7 HYDROXYPHENYL)ETHANAMIDE HETNAM TLA L(+)-TARTARIC ACID HETNAM CL CHLORIDE ION HETNAM N1L 2-AMINO-2-DEOXY-BETA-D-GLUCOPYRANURONIC ACID HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM M12 10-METHYLUNDECANOIC ACID HETSYN N1L 2-AMINO-2-DEOXY-BETA-D-GLUCURONIC ACID; 2-AMINO-2- HETSYN 2 N1L DEOXY-D-GLUCURONIC ACID; 2-AMINO-2-DEOXY-GLUCURONIC HETSYN 3 N1L ACID HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 1 CCS 4(C5 H9 N O4 S) FORMUL 1 DAL 8(C3 H7 N O2) FORMUL 5 HGM 4(C9 H11 N O3) FORMUL 5 DTY 4(C9 H11 N O3) FORMUL 5 HCL 4(C8 H8 CL N O4) FORMUL 5 GHP 8(C8 H9 N O3) FORMUL 5 OMY 4(C9 H10 CL N O4) FORMUL 5 HG7 4(C13 H21 N3 O2) FORMUL 9 TLA 4(C4 H6 O6) FORMUL 13 CL CL 1- FORMUL 14 N1L 4(C6 H11 N O6) FORMUL 15 MAN 4(C6 H12 O6) FORMUL 16 M12 4(C12 H24 O2) FORMUL 26 HOH *15(H2 O) HELIX 1 1 THR A 22 GLY A 35 1 14 HELIX 2 2 PRO A 37 ASP A 39 5 3 HELIX 3 3 THR B 22 GLY B 35 1 14 HELIX 4 4 PRO B 37 ASP B 39 5 3 HELIX 5 5 THR C 22 GLY C 35 1 14 HELIX 6 6 PRO C 37 ASP C 39 5 3 HELIX 7 7 THR D 22 GLY D 35 1 14 HELIX 8 8 PRO D 37 ASP D 39 5 3 SHEET 1 A 5 THR A 12 GLU A 16 0 SHEET 2 A 5 GLN A 2 LYS A 6 -1 N VAL A 5 O ILE A 13 SHEET 3 A 5 THR A 66 LEU A 71 1 O LEU A 67 N LYS A 6 SHEET 4 A 5 GLN A 41 PHE A 45 -1 N ILE A 44 O HIS A 68 SHEET 5 A 5 LYS A 48 GLN A 49 -1 O LYS A 48 N PHE A 45 SHEET 1 B 5 THR B 12 GLU B 16 0 SHEET 2 B 5 GLN B 2 LYS B 6 -1 N VAL B 5 O ILE B 13 SHEET 3 B 5 THR B 66 LEU B 71 1 O LEU B 67 N PHE B 4 SHEET 4 B 5 GLN B 41 PHE B 45 -1 N ILE B 44 O HIS B 68 SHEET 5 B 5 LYS B 48 GLN B 49 -1 O LYS B 48 N PHE B 45 SHEET 1 C 5 THR C 12 GLU C 16 0 SHEET 2 C 5 GLN C 2 LYS C 6 -1 N VAL C 5 O ILE C 13 SHEET 3 C 5 THR C 66 LEU C 71 1 O LEU C 67 N LYS C 6 SHEET 4 C 5 GLN C 41 PHE C 45 -1 N ILE C 44 O HIS C 68 SHEET 5 C 5 LYS C 48 GLN C 49 -1 O LYS C 48 N PHE C 45 SHEET 1 D 2 DAL C 78 DAL C 79 0 SHEET 2 D 2 GHP G 4 GHP G 5 -1 O GHP G 4 N DAL C 79 SHEET 1 E 5 THR D 12 GLU D 16 0 SHEET 2 E 5 GLN D 2 LYS D 6 -1 N VAL D 5 O ILE D 13 SHEET 3 E 5 THR D 66 LEU D 71 1 O LEU D 69 N LYS D 6 SHEET 4 E 5 GLN D 41 PHE D 45 -1 N ILE D 44 O HIS D 68 SHEET 5 E 5 LYS D 48 GLN D 49 -1 O LYS D 48 N PHE D 45 LINK C LYS A 77 N DAL A 78 1555 1555 1.33 LINK C DAL A 78 N DAL A 79 1555 1555 1.33 LINK C LYS B 77 N DAL B 78 1555 1555 1.33 LINK C DAL B 78 N DAL B 79 1555 1555 1.33 LINK C LYS C 77 N DAL C 78 1555 1555 1.33 LINK C DAL C 78 N DAL C 79 1555 1555 1.33 LINK C LYS D 77 N DAL D 78 1555 1555 1.33 LINK C DAL D 78 N DAL D 79 1555 1555 1.33 LINK C HGM E 1 N DTY E 2 1555 1555 1.34 LINK C3 HGM E 1 O4 HCL E 3 1555 1555 1.37 LINK C DTY E 2 N HCL E 3 1555 1555 1.34 LINK OH DTY E 2 C3 GHP E 4 1555 1555 1.39 LINK C HCL E 3 N GHP E 4 1555 1555 1.34 LINK C GHP E 4 N GHP E 5 1555 1555 1.33 LINK C5 GHP E 4 OCZ OMY E 6 1555 1555 1.40 LINK O4 GHP E 4 C1 N1L E 8 1555 1555 1.38 LINK C GHP E 5 N OMY E 6 1555 1555 1.34 LINK C3 GHP E 5 C6 HG7 E 7 1555 1555 1.40 LINK C OMY E 6 N HG7 E 7 1555 1555 1.33 LINK C5 HG7 E 7 O1 MAN E 9 1555 1555 1.39 LINK N2 N1L E 8 C1 M12 E 10 1555 1555 1.44 LINK C HGM F 1 N DTY F 2 1555 1555 1.33 LINK C3 HGM F 1 O4 HCL F 3 1555 1555 1.36 LINK C DTY F 2 N HCL F 3 1555 1555 1.33 LINK OH DTY F 2 C3 GHP F 4 1555 1555 1.39 LINK C HCL F 3 N GHP F 4 1555 1555 1.34 LINK C GHP F 4 N GHP F 5 1555 1555 1.33 LINK C5 GHP F 4 OCZ OMY F 6 1555 1555 1.39 LINK O4 GHP F 4 C1 N1L F 8 1555 1555 1.39 LINK C GHP F 5 N OMY F 6 1555 1555 1.33 LINK C3 GHP F 5 C6 HG7 F 7 1555 1555 1.40 LINK C OMY F 6 N HG7 F 7 1555 1555 1.34 LINK C5 HG7 F 7 O1 MAN F 9 1555 1555 1.39 LINK N2 N1L F 8 C1 M12 F 10 1555 1555 1.20 LINK C HGM G 1 N DTY G 2 1555 1555 1.34 LINK C3 HGM G 1 O4 HCL G 3 1555 1555 1.36 LINK C DTY G 2 N HCL G 3 1555 1555 1.33 LINK OH DTY G 2 C3 GHP G 4 1555 1555 1.39 LINK C HCL G 3 N GHP G 4 1555 1555 1.33 LINK C GHP G 4 N GHP G 5 1555 1555 1.33 LINK C5 GHP G 4 OCZ OMY G 6 1555 1555 1.39 LINK O4 GHP G 4 C1 N1L G 8 1555 1555 1.39 LINK C GHP G 5 N OMY G 6 1555 1555 1.32 LINK C3 GHP G 5 C6 HG7 G 7 1555 1555 1.40 LINK C OMY G 6 N HG7 G 7 1555 1555 1.34 LINK C5 HG7 G 7 O1 MAN G 9 1555 1555 1.39 LINK N2 N1L G 8 C1 M12 G 10 1555 1555 1.27 LINK C HGM H 1 N DTY H 2 1555 1555 1.34 LINK C3 HGM H 1 O4 HCL H 3 1555 1555 1.36 LINK C DTY H 2 N HCL H 3 1555 1555 1.33 LINK OH DTY H 2 C3 GHP H 4 1555 1555 1.39 LINK C HCL H 3 N GHP H 4 1555 1555 1.33 LINK C GHP H 4 N GHP H 5 1555 1555 1.33 LINK C5 GHP H 4 OCZ OMY H 6 1555 1555 1.39 LINK O4 GHP H 4 C1 N1L H 8 1555 1555 1.39 LINK C GHP H 5 N OMY H 6 1555 1555 1.33 LINK C3 GHP H 5 C6 HG7 H 7 1555 1555 1.40 LINK C OMY H 6 N HG7 H 7 1555 1555 1.33 LINK C5 HG7 H 7 O1 MAN H 9 1555 1555 1.39 LINK N2 N1L H 8 C1 M12 H 10 1555 1555 1.16 CISPEP 1 GHP E 5 OMY E 6 0 1.45 CISPEP 2 GHP F 5 OMY F 6 0 -20.80 CISPEP 3 GHP H 5 OMY H 6 0 -0.65 CRYST1 53.300 86.250 107.190 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018762 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011594 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009329 0.00000 MTRIX1 1 0.042641 0.332348 0.942193 -43.87140 1 MTRIX2 1 0.337421 -0.892431 0.299524 0.66681 1 MTRIX3 1 0.940388 0.305143 -0.150195 48.01840 1 MTRIX1 2 0.290096 0.319267 0.902171 -26.21560 1 MTRIX2 2 -0.233893 -0.890468 0.390334 -39.21610 1 MTRIX3 2 0.927975 -0.324246 -0.183647 7.45685 1 MTRIX1 3 0.804344 -0.593734 -0.022592 -51.01730 1 MTRIX2 3 0.590490 0.803015 -0.080544 28.84530 1 MTRIX3 3 0.065963 0.051444 0.996495 9.31183 1 MTRIX1 4 0.019530 0.318639 0.947675 -44.95700 1 MTRIX2 4 0.342244 -0.892724 0.293110 0.83030 1 MTRIX3 4 0.939408 0.318611 -0.126487 47.21720 1 MTRIX1 5 0.279748 0.336068 0.899332 -26.11280 1 MTRIX2 5 -0.216497 -0.890524 0.400121 -39.41470 1 MTRIX3 5 0.935345 -0.306636 -0.176365 7.59471 1 MTRIX1 6 0.787644 -0.616079 -0.007991 -52.47730 1 MTRIX2 6 0.612367 0.784199 -0.100194 27.91820 1 MTRIX3 6 0.067994 0.074024 0.994936 10.19730 1 MTRIX1 7 0.016811 0.311385 0.950135 -44.95330 1 MTRIX2 7 0.309728 -0.905148 0.291161 -0.06651 1 MTRIX3 7 0.950677 0.289389 -0.111661 47.76260 1 MTRIX1 8 0.270340 0.339946 0.900751 -25.79650 1 MTRIX2 8 -0.248269 -0.879331 0.406374 -39.09130 1 MTRIX3 8 0.930204 -0.333488 -0.153320 6.83843 1 MTRIX1 9 0.823752 -0.565994 -0.032909 -49.47560 1 MTRIX2 9 0.562263 0.823013 -0.080690 30.03850 1 MTRIX3 9 0.072754 0.047965 0.996196 8.74839 1 MTRIX1 10 0.040060 0.301969 0.952476 -44.08300 1 MTRIX2 10 0.306461 -0.911012 0.275934 0.29812 1 MTRIX3 10 0.951040 0.280842 -0.129036 48.35230 1 MTRIX1 11 0.290098 0.313157 0.904310 -26.61990 1 MTRIX2 11 -0.275433 -0.877641 0.392279 -38.73210 1 MTRIX3 11 0.916504 -0.362876 -0.168348 6.45786 1 MTRIX1 12 0.809319 -0.587332 -0.006598 -50.59970 1 MTRIX2 12 0.585279 0.807336 -0.075205 29.13010 1 MTRIX3 12 0.049498 0.057004 0.997146 9.37592 1 MTRIX1 13 0.034601 0.324270 0.945332 -44.24180 1 MTRIX2 13 0.321840 -0.899124 0.296639 0.11324 1 MTRIX3 13 0.946162 0.293981 -0.135474 48.20070 1 MTRIX1 14 0.278826 0.334245 0.900298 -25.94860 1 MTRIX2 14 -0.243291 -0.882309 0.402915 -39.22590 1 MTRIX3 14 0.929013 -0.331377 -0.164692 7.15270 1 MTRIX1 15 0.796158 -0.605080 0.003410 -51.54620 1 MTRIX2 15 0.602643 0.792420 -0.094301 28.38960 1 MTRIX3 15 0.054357 0.077134 0.995538 10.45750 1 MTRIX1 16 0.160661 0.316142 0.935009 -41.04060 1 MTRIX2 16 0.285563 -0.921689 0.262570 0.18144 1 MTRIX3 16 0.944797 0.224819 -0.238358 51.95830 1 MTRIX1 17 0.319211 0.261264 0.910959 -29.09890 1 MTRIX2 17 -0.314040 -0.877774 0.361790 -37.47070 1 MTRIX3 17 0.894138 -0.401564 -0.198147 6.05066 1 MTRIX1 18 0.823700 -0.563748 0.060886 -50.80230 1 MTRIX2 18 0.567020 0.818448 -0.092904 29.88390 1 MTRIX3 18 0.002543 0.111048 0.993812 12.64860 1 MTRIX1 19 0.804225 -0.591970 0.052853 -52.03940 1 MTRIX2 19 0.594302 0.800239 -0.080135 27.68250 1 MTRIX3 19 0.005143 0.095857 0.995382 11.79170 1